The impact of mammographic breast density on locoregional recurrence in breast cancer: a systematic review and meta-analysis.

IF 3 3区 医学 Q2 ONCOLOGY
Lily Nolan, Huilun Huan, William McDonnell, Stewart Walsh, Aoife Lowery
{"title":"The impact of mammographic breast density on locoregional recurrence in breast cancer: a systematic review and meta-analysis.","authors":"Lily Nolan, Huilun Huan, William McDonnell, Stewart Walsh, Aoife Lowery","doi":"10.1007/s10549-025-07804-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Understanding locoregional recurrence (LRR) risk is important in breast cancer, as it relates directly to breast cancer-associated mortality. Individualised LRR risk estimation should inform treatment and surveillance strategies. Increased mammographic breast density has been identified as a risk factor for the development of breast cancer. However, the precise relationship between mammographic density and breast cancer LRR remains unclear.</p><p><strong>Aims: </strong>To perform a systematic review and relative risk meta-analysis to explore the assocation between breast mammographic density and breast cancer LRR.</p><p><strong>Methods: </strong>A systematic review was performed as per PRISMA guidelines. Mammographic breast density (MBD) was classified as BI-RADs A-B (breast density < 50%, predominately fatty or scattered areas of fibroglandular density) or BI-RADs C-D breast density > 50%, heterogeneously dense or extremely dense). A meta-anlysis was performed using Meta-Disc and Statsdirect 2.8.0.</p><p><strong>Results: </strong>Seven studies published between 2004 and 2023 met the inclusion criteria, comprising 3008 patients with reported mammographic breast density (MBD) (age range: 20-94 years). Overall, 59.1% (1779/3008) were classified as low MBD (BI-RADS A-B) and 40.9% (1229/3008) were classified as high MBD (BI-RADS C-D). Of these patients, 68.9% (2073/3008) were treated for invasive breast carcinoma and 31.1% had ductal carcinoma in-situ (DCIS). Breast-conserving surgery (BCS) was performed in 71.1% (2139/3008) of patients, mastectomy was performed in 28.2% (850/3008),. The median follow-up was 94.1 months, and the overall LRR rate was 12.8% (386/3008). Five of the seven studies reported a correlation between BI-RADs C-D and the development of LRR. LRR rates were lower in patients with low mammographic breast density (9.9% for BI-RADS A-B (177/1779)) compared to those with higher mammogaphic breast density (17.0% for BI-RADs C-D. (209/1229)) [P < 0.001, Chi Square]. BI-RADS C-D density on mammography was associated with an increased risk of locoregional recurrence (pooled relative risk 1.41; 95% confidence interval 1.17 to 1.70).</p><p><strong>Conclusion: </strong>Increased mammographic breast density may be associated with an increased risk of LRR. Multidisciplinary team discussions should consider MBD as a potential prognostic factor in when considering surveillance and locoregional control after breast cancer treatment.</p>","PeriodicalId":9133,"journal":{"name":"Breast Cancer Research and Treatment","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10549-025-07804-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Understanding locoregional recurrence (LRR) risk is important in breast cancer, as it relates directly to breast cancer-associated mortality. Individualised LRR risk estimation should inform treatment and surveillance strategies. Increased mammographic breast density has been identified as a risk factor for the development of breast cancer. However, the precise relationship between mammographic density and breast cancer LRR remains unclear.

Aims: To perform a systematic review and relative risk meta-analysis to explore the assocation between breast mammographic density and breast cancer LRR.

Methods: A systematic review was performed as per PRISMA guidelines. Mammographic breast density (MBD) was classified as BI-RADs A-B (breast density < 50%, predominately fatty or scattered areas of fibroglandular density) or BI-RADs C-D breast density > 50%, heterogeneously dense or extremely dense). A meta-anlysis was performed using Meta-Disc and Statsdirect 2.8.0.

Results: Seven studies published between 2004 and 2023 met the inclusion criteria, comprising 3008 patients with reported mammographic breast density (MBD) (age range: 20-94 years). Overall, 59.1% (1779/3008) were classified as low MBD (BI-RADS A-B) and 40.9% (1229/3008) were classified as high MBD (BI-RADS C-D). Of these patients, 68.9% (2073/3008) were treated for invasive breast carcinoma and 31.1% had ductal carcinoma in-situ (DCIS). Breast-conserving surgery (BCS) was performed in 71.1% (2139/3008) of patients, mastectomy was performed in 28.2% (850/3008),. The median follow-up was 94.1 months, and the overall LRR rate was 12.8% (386/3008). Five of the seven studies reported a correlation between BI-RADs C-D and the development of LRR. LRR rates were lower in patients with low mammographic breast density (9.9% for BI-RADS A-B (177/1779)) compared to those with higher mammogaphic breast density (17.0% for BI-RADs C-D. (209/1229)) [P < 0.001, Chi Square]. BI-RADS C-D density on mammography was associated with an increased risk of locoregional recurrence (pooled relative risk 1.41; 95% confidence interval 1.17 to 1.70).

Conclusion: Increased mammographic breast density may be associated with an increased risk of LRR. Multidisciplinary team discussions should consider MBD as a potential prognostic factor in when considering surveillance and locoregional control after breast cancer treatment.

乳房x光检查乳腺密度对乳腺癌局部复发的影响:系统回顾和荟萃分析。
背景:了解乳腺癌局部区域复发(LRR)风险是很重要的,因为它直接关系到乳腺癌相关的死亡率。个体化LRR风险评估应为治疗和监测策略提供信息。乳房x光检查中乳房密度增加已被确定为乳腺癌发展的一个危险因素。然而,乳房x线摄影密度与乳腺癌LRR之间的确切关系尚不清楚。目的:通过系统回顾和相对风险荟萃分析,探讨乳腺x线摄影密度与乳腺癌LRR之间的关系。方法:按照PRISMA指南进行系统评价。乳腺x线摄影乳腺密度(MBD)被分类为BI-RADs A-B(乳腺密度50%,非均匀致密或极度致密)。采用Meta-Disc软件和Statsdirect 2.8.0软件进行meta分析。结果:2004年至2023年间发表的7项研究符合纳入标准,包括3008例报告乳房x线摄影乳房密度(MBD)的患者(年龄范围:20-94岁)。总体而言,59.1%(1779/3008)的患者被归为低MBD (BI-RADS A-B), 40.9%(1229/3008)的患者被归为高MBD (BI-RADS C-D)。其中68.9%(2073/3008)为浸润性乳腺癌,31.1%为导管原位癌(DCIS)。71.1%(2139/3008)的患者行保乳手术,28.2%(850/3008)的患者行乳房切除术。中位随访为94.1个月,总LRR率为12.8%(386/3008)。七项研究中有五项报告了BI-RADs C-D与LRR发展之间的相关性。低乳腺密度患者的LRR率(BI-RADS A-B组为9.9%(177/1779))低于高乳腺密度患者(BI-RADS C-D组为17.0%)。(209/1229)结论:乳腺密度增高可能与LRR风险增高有关。在考虑乳腺癌治疗后的监测和局部控制时,多学科小组讨论应考虑MBD作为潜在的预后因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.80
自引率
2.60%
发文量
342
审稿时长
1 months
期刊介绍: Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信